Mumbai, Jan. 30 -- MOIL has revised the record date for purpose of interim dividend for FY 2024-25 to 15 February 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
ಭಾರತ, ಜನವರಿ 30 -- ನಮಗೆ ತಿಳಿಯದೆ ನಾವು ಮಾಡುವ ಸಣ್ಣ ತಪ್ಪುಗಳು ಸಹ ನಮ್ಮ ಜೀವನದ ಮೇಲೆ ದೊಡ್ಡ ಪರಿಣಾಮ ಬೀರಬಹುದು. ಜ್ಯೋತಿಷ್ಯದ ಪ್ರಕಾರ, ಕೆಲವು ತಪ್ಪುಗಳಿಂದಾಗಿ ಭಾರಿ ನಷ್ಟವನ್ನು ಎದುರಿಸಬೇಕಾಗಬಹುದು. ಕುಳಿತುಕೊಂಡಾಗ ಕೆಲವರಿಗೆ ಕಾಲು ಅಲ್... Read More
Mumbai, Jan. 30 -- Profit before tax (PBT) stood at Rs 7,674 crore during the December 2024 quarter, down 0.17% from Rs 7,687 crore posted in the same quarter last year. EBITDA stood at Rs 15,521 cro... Read More
இந்தியா, ஜனவரி 30 -- நாம் சாப்பிடும் ஒவ்வொரு விதமான காய்கறிகளிலும் ஒவ்வொரு விதமான ஊட்டச்சத்து நிறைந்துள்ளது. இது போன்ற காய்கறிகளை அன்றாடம் உணவில் சேர்த்துக் கொள்ள வேண்டும். தமிழ்நாடு உணவு முறையும் காய... Read More
Mumbai, Jan. 30 -- The key equity benchmarks traded with modest gains in the morning trade. The Nifty climbed above the 23,250 mark. Realty shares witnessed buying demand for the third consecutive tra... Read More
U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799273) titled 'MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardi... Read More
U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06797882) titled 'Preventive Effects of Silver Diamine Fluoride on Early Enamel Caries' on Jan. 27. Brief Su... Read More
U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06800066) titled 'RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims' on Jan. 06. Brief Summary: Ca... Read More
U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799182) titled 'Periodontal Disease and Colorectal Cancer' on Jan. 15. Brief Summary: The aim of this inte... Read More
U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799065) titled 'First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or ... Read More